{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T12:32:48Z","timestamp":1777638768340,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"National Agency for Science and Technology Promotion","award":["PICT 2016 N\u00b0 0548"],"award-info":[{"award-number":["PICT 2016 N\u00b0 0548"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental and Molecular Pathology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.yexmp.2019.03.005","type":"journal-article","created":{"date-parts":[[2019,3,12]],"date-time":"2019-03-12T11:57:29Z","timestamp":1552391849000},"page":"24-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Overexpression of survivin in pediatric Hodgkin lymphoma tumor cells: Characterization of protein expression and splice-variants transcription profile"],"prefix":"10.1016","volume":"108","author":[{"given":"Mario Alejandro","family":"Lorenzetti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jimena","family":"Mosna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena Noem\u00ed","family":"De Matteo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mercedes","family":"Garc\u00eda Lombardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra Lorena","family":"Colli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Victoria","family":"Preciado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexmp.2019.03.005_bb0005","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1089\/lrb.2007.5305","article-title":"Prognostic significance of cell proliferation and apoptosis-regulating proteins in Epstein-Barr virus positive and negative pediatric Hodgkin lymphoma","volume":"5","author":"Aktas","year":"2007","journal-title":"Lymphat. Res. Biol."},{"key":"10.1016\/j.yexmp.2019.03.005_bb0010","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s12253-008-9127-8","article-title":"Prognostic significance of cell proliferation and apoptosis-regulating proteins in Epstein-Barr virus positive and negative pediatric non-Hodgkin's lymphoma","volume":"15","author":"Aktas","year":"2009","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.yexmp.2019.03.005_bb0015","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.canlet.2015.10.007","article-title":"Microenvironmental interactions in classical Hodgkin lymphoma and their role in promoting tumor growth, immune escape and drug resistance","volume":"380","author":"Aldinucci","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.yexmp.2019.03.005_bb0020","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.mayocp.2015.07.005","article-title":"Hodgkin lymphoma: diagnosis and treatment","volume":"90","author":"Ansell","year":"2015","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.yexmp.2019.03.005_bb0025","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1038\/cti.2015.1","article-title":"Infectious mononucleosis","volume":"4","author":"Balfour","year":"2015","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.yexmp.2019.03.005_bb0030","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","article-title":"The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments","volume":"55","author":"Bustin","year":"2009","journal-title":"Clin. Chem."},{"key":"10.1016\/j.yexmp.2019.03.005_bb0035","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1038\/s41598-018-20133-6","article-title":"Frequency of EBV associated classical Hodgkin lymphoma decreases over a 54-year period in a Brazilian population","volume":"8","author":"Campos","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yexmp.2019.03.005_bb0040","first-page":"10","article-title":"Epstein barr virus-associated hodgkin lymphoma","author":"Carbone","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.yexmp.2019.03.005_bb0045","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/ijc.27858","article-title":"EBV primary infection in childhood and its relation to B-cell lymphoma development: a mini-review from a developing region","volume":"133","author":"Chabay","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.yexmp.2019.03.005_bb0050","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.virusres.2009.07.005","article-title":"The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: a need for reappraisal","volume":"143","author":"Chang","year":"2009","journal-title":"Virus Res."},{"key":"10.1016\/j.yexmp.2019.03.005_bb0055","doi-asserted-by":"crossref","first-page":"314","DOI":"10.7150\/jca.13332","article-title":"Survivin and tumorigenesis: molecular mechanisms and therapeutic strategies","volume":"7","author":"Chen","year":"2016","journal-title":"J. Cancer"},{"key":"10.1016\/j.yexmp.2019.03.005_bb0060","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1182\/blood-2002-04-1128","article-title":"Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: analyses using tissue microarrays","volume":"101","author":"Garcia","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.yexmp.2019.03.005_bb0065","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12935-016-0326-1","article-title":"Survivin: a unique target for tumor therapy","volume":"16","author":"Garg","year":"2016","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.yexmp.2019.03.005_bb0070","first-page":"5847","article-title":"Prognostic value of survivin in patients with non-Hodgkin's lymphoma: a meta-analysis","volume":"8","author":"He","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.yexmp.2019.03.005_bb0075","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1158\/0008-5472.CAN-07-3027","article-title":"Survival advantage of EBV-associated gastric carcinoma: survivin up-regulation by viral latent membrane protein 2A","volume":"68","author":"Hino","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexmp.2019.03.005_bb0080","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1600-0463.2012.02962.x","article-title":"Expression of apoptosis associated proteins Survivin, Livin and Thrombospondin-1 in Burkitt lymphoma","volume":"121","author":"Kalungi","year":"2013","journal-title":"APMIS"},{"key":"10.1016\/j.yexmp.2019.03.005_bb0085","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/med.21264","article-title":"Survivin signaling in clinical oncology: a multifaceted dragon","volume":"33","author":"Kanwar","year":"2013","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.yexmp.2019.03.005_bb0090","first-page":"57","article-title":"Localization and upregulation of survivin in cancer health disparities: a clinical perspective","volume":"9","author":"Khan","year":"2015","journal-title":"Biologics."},{"key":"10.1016\/j.yexmp.2019.03.005_bb0095","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/PAP.0000000000000002","article-title":"Hodgkin lymphoma: pathology, pathogenesis, and a plethora of potential prognostic predictors","volume":"21","author":"King","year":"2014","journal-title":"Adv. Anat. Pathol."},{"issue":"Suppl. 1","key":"10.1016\/j.yexmp.2019.03.005_bb0100","doi-asserted-by":"crossref","first-page":"S158","DOI":"10.1016\/j.canep.2016.07.016","article-title":"Hodgkin lymphoma burden in Central and South America","volume":"44","author":"Kusminsky","year":"2016","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.yexmp.2019.03.005_bb0105","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1745-7254.2008.00750.x","article-title":"Expression of PLK1 and survivin in non-Hodgkin's lymphoma treated with CHOP","volume":"29","author":"Liu","year":"2008","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.yexmp.2019.03.005_bb0110","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.virol.2010.10.029","article-title":"Epstein-Barr virus nuclear antigen 1 (EBNA1) confers resistance to apoptosis in EBV-positive B-lymphoma cells through up-regulation of survivin","volume":"410","author":"Lu","year":"2011","journal-title":"Virology."},{"key":"10.1016\/j.yexmp.2019.03.005_bb0115","series-title":"ROHA, Registro Oncopedi\u00e1trico Hospitalario Argentino. Incidencia 2000\u20132013. Supervivencia 2000-2009. Tendencia de mortalidad 2000-2013","first-page":"1","volume":"vol. 1","author":"Moreno","year":"2013"},{"key":"10.1016\/j.yexmp.2019.03.005_bb0120","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/sj.bjc.6604253","article-title":"The clinical significance of splice variants and subcellular localisation of survivin in non-small cell lung cancers","volume":"98","author":"Nakano","year":"2008","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.yexmp.2019.03.005_bb0125","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.canlet.2013.06.007","article-title":"Clinico-pathologic relevance of Survivin splice variant expression in cancer","volume":"339","author":"Necochea-Campion","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.yexmp.2019.03.005_bb0130","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.3748\/wjg.v17.i12.1614","article-title":"Survivin isoforms and clinicopathological characteristics in colorectal adenocarcinomas using real-time qPCR","volume":"17","author":"Pavlidou","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.yexmp.2019.03.005_bb0135","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.yexmp.2019.03.005_bb0140","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.2174\/092986712801661040","article-title":"Survivin as a prognostic\/predictive marker and molecular target in cancer therapy","volume":"19","author":"Rodel","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.yexmp.2019.03.005_bb0145","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.3892\/or.2015.3847","article-title":"LMP-1 induces survivin expression to inhibit cell apoptosis through the NF-kappaB and PI3K\/Akt signaling pathways in nasal NK\/T-cell lymphoma","volume":"33","author":"Sun","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.yexmp.2019.03.005_bb0150","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.yexmp.2019.03.005_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens7020040","article-title":"The microenvironment in Epstein-Barr virus-associated malignancies","volume":"7","author":"Tan","year":"2018","journal-title":"Pathogens"},{"key":"10.1016\/j.yexmp.2019.03.005_bb0160","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1369\/jhc.2007.950170","article-title":"Multiple immunoenzyme staining: methods and visualizations for the observation with spectral imaging","volume":"56","author":"van der Loos","year":"2008","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.yexmp.2019.03.005_bb0165","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/978-1-62703-547-7_13","article-title":"Assessment of mRNA splice variants by qRT-PCR","volume":"1049","author":"Vargas","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.yexmp.2019.03.005_bb0170","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/70487","article-title":"Analysis of human transcriptomes","volume":"23","author":"Velculescu","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.yexmp.2019.03.005_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens7030059","article-title":"Contribution of Epstein Barr virus latent proteins to the pathogenesis of classical Hodgkin lymphoma","volume":"7","author":"Vrzalikova","year":"2018","journal-title":"Pathogens."},{"key":"10.1016\/j.yexmp.2019.03.005_bb0180","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.3892\/ol.2017.5713","article-title":"Survivin DEx3 as a biomarker of thyroid cancers: a study at the mRNA and protein level","volume":"13","author":"Waligorska-Stachura","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.yexmp.2019.03.005_bb0185","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/PAI.0b013e3181a13bf2","article-title":"Survivin expression quantified by image pro-plus compared with visual assessment","volume":"17","author":"Wang","year":"2009","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"10.1016\/j.yexmp.2019.03.005_bb0190","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nrc.2016.92","article-title":"Epstein-Barr virus: more than 50 years old and still providing surprises","volume":"16","author":"Young","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.yexmp.2019.03.005_bb0195","article-title":"Prognostic and clinicopathological value of survivin in diffuse large B-cell lymphoma: a meta-analysis","volume":"94","author":"Zhang","year":"2015","journal-title":"Medicine (Baltimore)"}],"container-title":["Experimental and Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480018305999?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480018305999?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T02:47:46Z","timestamp":1757990866000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014480018305999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":39,"alternative-id":["S0014480018305999"],"URL":"https:\/\/doi.org\/10.1016\/j.yexmp.2019.03.005","relation":{},"ISSN":["0014-4800"],"issn-type":[{"value":"0014-4800","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overexpression of survivin in pediatric Hodgkin lymphoma tumor cells: Characterization of protein expression and splice-variants transcription profile","name":"articletitle","label":"Article Title"},{"value":"Experimental and Molecular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexmp.2019.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}